Who We Are

Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.
Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.
Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.
Key Issues
Causes We Care About, and So Should You!

HIV
Promote necessary funding, programs, and policies to end the HIV epidemic in the United States

HEPATITIS
Promote necessary funding, programs, and policies to end viral hepatitis in the United States

HEALTHCARE ACCESS
Promote necessary funding, programs, and policies to end viral hepatitis in the United States
Facebook posts by @HIV+Hep
www.linkedin.com
🎥 We’re excited to share the first part of our interview with Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, this afternoon! #HIVAwarenessMonth Following the Supreme Court...FDA approves twice-yearly injectable PrEP
gaycitynews.com
The approval comes more than three years after cabotegravir, which is offered by ViiV Healthcare under the name Apretude, was approved as an injectable formA Cautionary Victory for Now: More About the Supreme Court’s Ruling on Preventive Health Care
www.poz.com
A roundup of statements on “Kennedy v. Braidwood.” The ruling upholds insurance coverage of cost-free preventive services.www.ilcn.org
Advocate and best-selling author Annabelle Gurwitch shines light on pharmacy benefit practices that cost patients thousands while increasing profits for insurance companies.Supreme Court Issues Ruling on ACA's Preventive Care Mandate
www.medpagetoday.com
The 6-3 ruling is hailed by one health group as a 'great victory for healthcare in our country'